PRL modulates cell cycle regulators in mammary tumor epithelial cells

被引:85
作者
Schroeder, MD [1 ]
Symowicz, J [1 ]
Schuler, LA [1 ]
机构
[1] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA
关键词
D O I
10.1210/me.16.1.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PRL is essential for normal lobulo-alveolar growth of the mammary gland and may contribute to mammary cancer development or progression. However, analysis of the mechanism of action of PRL in these processes is complicated by the production of PRL within mammary epithelia. To examine PRL actions in a mammary cell-specific context, we selected MCF-7 cells that lacked endogenous PRL synthesis, using PRL stimulation of interferon-gamma -activated sequence-related PRL response elements. Derived clones exhibited a greater proliferative response to PRIL than control cells. To understand the mechanism, we examined, by Western analysis, levels of proteins essential for cell cycle progression as well as phosphorylation of retinoblastoma protein. The expression of cyclin D-1, a critical regulator of the G(1)/S transition, was significantly increased by PRL and was associated with hyperphosphorylation of retinoblastoma protein at Ser(780). Cyclin BI was also increased by PRL. In contrast, PRL decreased the Cip/Kip family inhibitor, p21, but not p16 or p27. These studies demonstrate that PRL can stimulate the cell cycle in mammary epithelia and identify specific targets in this process. This model system will enable further molecular dissection of the pathways involved in PRL-induced proliferation, increasing our understanding of this hormone and its interactions with other factors in normal and pathogenic processes.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 66 条
[21]   PROLACTIN RECEPTOR ANTAGONISTS THAT INHIBIT THE GROWTH OF BREAST-CANCER CELL-LINES [J].
FUH, G ;
WELLS, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13133-13137
[22]   Interactions among JANUS kinases and the prolactin (PRL) receptor in the regulation of a PRL response element [J].
Gao, J ;
Hughes, JP ;
Auperin, B ;
Buteau, H ;
Edery, M ;
Zhuang, HM ;
Wojchowski, DM ;
Horseman, ND .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (07) :847-856
[23]   Transcriptional regulation of the p21(WAF1/ClP1) gene [J].
Gartel, AL ;
Tyner, AL .
EXPERIMENTAL CELL RESEARCH, 1999, 246 (02) :280-289
[24]   Should prolactin be reconsidered as a therapeutic target in human breast cancer? [J].
Goffin, V ;
Touraine, P ;
Pichard, C ;
Bernichtein, S ;
Kelly, PA .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 151 (1-2) :79-87
[25]  
Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335
[26]  
GOUT PW, 1980, CANCER RES, V40, P2433
[27]   Defining the substrate specificity of cdk4 kinase-cyclin D1 complex [J].
Grafstrom, RH ;
Pan, WJ ;
Hoess, RH .
CARCINOGENESIS, 1999, 20 (02) :193-198
[28]   Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women [J].
Hankinson, SE ;
Willett, WC ;
Michaud, S ;
Manson, JE ;
Colditz, GA ;
Longcope, C ;
Rosner, B ;
Speizer, FE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (07) :629-634
[29]   Prolactin signaling in mammary gland development [J].
Hennighausen, L ;
Robinson, GW ;
Wagner, KU ;
Liu, XW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :7567-7569
[30]  
Hershko A, 1996, ADV EXP MED BIOL, V389, P221